Medifast (STU:MDF) Cyclically Adjusted Revenue per Share: €71.98 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:MDF Medifast Inc STU:MDF
66 GF Score
Price €10.78
GF Value €7.30
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Medifast Cyclically Adjusted Revenue per Share?

Medifast STU:MDF -6.42% 66 Cyclically Adjusted Revenue per Share is €71.98 as of Jun. 2026. GuruFocus rates STU:MDF with a GF Score™ of 66/100 and a GF Value™ of €7.30 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medifast's adjusted revenue per share for the three months ended in Jun. 2026 was €5.954. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €71.98 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Medifast's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 16.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 19.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Medifast was 35.10% per year. The lowest was 7.80% per year. And the median was 19.80% per year.

As of today (2026-08-06), Medifast's current stock price is €10.78. Medifast's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €71.98. Medifast's Cyclically Adjusted PS Ratio of today is 0.15.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medifast was 10.96. The lowest was 0.12. And the median was 2.39.


Medifast  (STU:MDF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medifast's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=10.78/71.98
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medifast was 10.96. The lowest was 0.12. And the median was 2.39.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medifast Cyclically Adjusted Revenue per Share Related Terms


Medifast Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Medifast's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medifast Cyclically Adjusted Revenue per Share Chart

Medifast Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.65 57.77 66.04 73.37 66.40

Medifast Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.35 68.63 66.40 69.89 71.98

STU:MDF vs RGS, CLIK, EVTK: Cyclically Adjusted Revenue per Share Comparison

For the Personal Services subindustry, Medifast's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medifast Cyclically Adjusted PS Ratio vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Medifast's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medifast's Cyclically Adjusted PS Ratio falls into.


STU:MDF
66GF Score
Medifast Inc STU:MDF
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medifast Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medifast's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=5.954/333.9520*333.9520
=5.954

Current CPI (Jun. 2026) = 333.9520.

Medifast Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 5.114 241.428 7.074
201612 4.930 241.432 6.819
201703 5.499 243.801 7.532
201706 5.590 244.955 7.621
201709 5.356 246.819 7.247
201712 5.419 246.524 7.341
201803 6.587 249.554 8.815
201806 8.249 251.989 10.932
201809 9.864 252.439 13.049
201812 10.701 251.233 14.224
201903 11.993 254.202 15.756
201906 13.553 256.143 17.670
201909 14.304 256.759 18.604
201912 12.855 256.974 16.706
202003 13.659 258.115 17.672
202006 16.526 257.797 21.408
202009 19.438 260.280 24.940
202012 18.330 260.474 23.501
202103 24.086 264.877 30.367
202106 27.591 271.696 33.913
202109 29.816 274.310 36.299
202112 28.502 278.802 34.140
202203 32.581 287.504 37.845
202206 37.504 296.311 42.268
202209 35.709 296.808 40.178
202212 28.950 296.797 32.574
202303 29.906 301.836 33.088
202306 25.042 305.109 27.409
202309 20.215 307.789 21.933
202312 16.057 306.746 17.481
202403 14.671 312.332 15.687
202406 14.317 314.175 15.218
202409 11.511 315.301 12.192
202412 10.355 315.605 10.957
202503 9.778 319.799 10.211
202506 8.275 322.561 8.567
202509 6.931 324.800 7.126
202512 5.834 324.054 6.012
202603 5.977 330.213 6.045
202606 5.954 333.952 5.954

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €71.98 mean?
Medifast (STU:MDF) has a Cyclically Adjusted Revenue per Share of €71.98 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medifast and its competitors.
Is Medifast's Cyclically Adjusted Revenue per Share too high?
Medifast's current Cyclically Adjusted Revenue per Share is €71.98. Overall, Medifast has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medifast's Cyclically Adjusted Revenue per Share compare to RGS and CLIK?
Medifast's Cyclically Adjusted Revenue per Share of €71.98 can be compared against companies in the Personal Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Personal Services company?
A good Cyclically Adjusted Revenue per Share depends on the Personal Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medifast and its competitors. Medifast's current Cyclically Adjusted Revenue per Share is €71.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Based on GuruFocus' analysis, Medifast (STU:MDF) is currently considered Significantly Overvalued. The stock's GF Value™ is €7.30, compared to a current price of €10.78 — trading 47.7% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €71.98. Medifast's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Medifast (STU:MDF), the current Cyclically Adjusted Revenue per Share is €71.98 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medifast (STU:MDF) Overvalued in 2026?

Based on GuruFocus' analysis, Medifast stock appears to be overvalued. The current stock price of €10.78 is trading 47.7% above its estimated GF Value™ of €7.30. GuruFocus considers Medifast to be Significantly Overvalued.

Key valuation signals for STU:MDF:

  • Cyclically Adjusted Revenue per Share: €71.98
  • GF Value™: €7.30 vs. price of €10.78 (47.7% above fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the STU:MDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medifast Business Description

Other Exchanges MED:USA0K05:UK
Address 100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
66GF Score

Get the complete analysis for STU:MDF

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.78
Price
€7.30
GF Value